UBC Medical Indonesia Tbk. vs Nusantara Almazia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Nusantara Almazia Tbk. trades at Rp135 (market cap 303.26B, 3.71M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.1× Nusantara Almazia Tbk.'s market cap, and Nusantara Almazia Tbk. is more actively traded (3.71M versus 848.2K). Which is the better fit depends on your goals.
| LABS | NZIA | |
|---|---|---|
Market Cap | 651.75B | 303.26B |
Volume | 848.2K | 3.71M |
Lot | 8.48K | 37.09K |
Turnover | 140.51M | 502.68M |
Average Price | 165.66 | 135.53 |
Value | 140.51M | 502.68M |
Indicative Equilibrium Price | 168 | 135 |
Indicative Equilibrium Volume | 50 | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Nusantara Almazia Tbk (the "Company") was incorporated under Deed No. 24 dated November 26, 2007 made by Ukon Krisnajaya, S.H., S.Pn,.
Read more on NZIA →